Glipizide
- Product NDC
- 62559-315
- 11-digit product format
- 625590315
- Labeler code
- 62559
- Product ID
- 62559-315_98923108-d10c-4282-b4fa-845bab2413c8
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Glipizide
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- ANI Pharmaceuticals, Inc.
- Application
- ANDA074497
- Marketing category
- ANDA
- Marketing start
- 2022-05-31
- Substance
- GLIPIZIDE
- Active strength
- 5 mg/1
- Pharmacologic classes
- Sulfonylurea Compounds [CS], Sulfonylurea [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Glipizide
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| GLIPIZIDE | 5 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | X7WDT95N5C |
| Rxcui | 310488, 310490 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 62559-315-10 | Glipizide | 1000 in 1 BOTTLE | TABLET | 1000 | | 7 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 62559-315 | GLIPIZIDE TABLET [ANI PHARMACEUTICALS, INC.] | 5 | Current NDC, Legacy NDC, 1 package rows | 20230113_252ba4e0-8dc3-43e3-be00-32570dc095bd.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 62559-315-10 | 62559031510 | 1000 TABLET in 1 BOTTLE (62559-315-10) | 1000 tablet | 2022-05-31 | 0000-00-00 | No | No | Current |